Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

Lancet Examines Leishmaniasis In East Africa
A Lancet world report examines the growing threat of visceral leishmaniasis on populations in eastern Africa. Each year, the parasitic disease affects around 500,000 people worldwide, killing roughly 50,000. Though "[t]wo-thirds of [leishmaniasis] patients are in southeast Asia ò€¦ the second largest foci is east Africa: perhaps as many as 40,000 cases every year, and incidence is on the rise," according to the article. The report explores the difficulty monitoring visceral leishmaniasis due to poor diagnostics and data surveillance, a surge in leishmania/HIV coinfection in Ethiopia and the Sudan, the shortcomings of the therapies available to treat visceral leishmaniasis, as well as future efforts to control the spread of the disease. Don't forget to buy zoloft online no prescription.

New Malaria Agent Found In Chimpanzees Close To That Commonly Observed In Humans
Researchers based in Gabon and France report the discovery of a new

generic viagra online


News of the day
A New Lead For Autoimmune Disease
A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children"s Hospital Boston (PCMM/IDI), along with the Harvard School of Dental Medicine. In the June 5 edition of Science, they show that a small-molecule compound known as halofuginone inhibits the development of Th17 cells, immune cells recently recognized as important players in autoimmune disease, without altering other kinds of T cells involved in normal immune function. They further demonstrate that halofuginone reduces disease pathology in a mouse model of autoimmunity.
Oncology

Association Between Rheumatoid Arthritis And Poor Sleep In Women

According to a research abstract that will be presented on Wednesday, June 10, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, symptoms of Rheumatoid Arthritis (RA) negatively affect women"s sleep. Sleep is further impaired by pain, depression and poor adherence to RA medications. Results indicate that length of time since RA diagnosis, RA disease activity, level of pain, depression symptoms and adherence to medications for RA may cause women suffering from the disease to have poor sleep quality. According to lead author Faith Luyster, PhD, of the University of Pittsburgh, Pa., findings emphasize the need for further research concerning poor RA medication adherence and sleep quality. "Treating depression in women with RA may not only improve sleep but may also improve pain and adherence to medications," said Luyster. The study involved 133 women with RA; their average age was 56 years, and they were primarily Caucasian, married, had at least a high school education, were not depressed and had RA for 14.76 years. A majority of participants (71 percent) reported poor sleep quality. Pain and depression were measured through subjective reports, and medication adherence was measured objectively with an electronic medication monitor on medication bottle caps. Sleep disturbances and depression are more prevalent in women in the general population. According to the American Academy of Sleep Medicine (AASM), women face many challenges that interfere with their sleep quality and duration. More information about how sleep affects women can be found at http://www.sleepeducation.com/Topic.aspx?id=67 Abstract Title: Sleep Quality in Women with Rheumatoid Arthritis Presentation Date: Wednesday, June 10 Category: Sleep in Medical Disorders Abstract ID: 1007 Kelly Wagner American Academy of Sleep Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009